[[p38]] [[signaling]] is broadly involved in controlling [[inflammation]] and stress-induced [[cell death]]; however, the mechanisms controlling its activity have seldom been studied. 

Liu et al. report that TRIM9 short isoform (TRIM9s) potentiates p38 signaling by stabilizing [[MKK6]]. Mechanistic studies revealed that TRIM9s promotes the [[K63]]-linked ubiquitination of MKK6 at [[Lys82]], thus inhibiting the degradative K48-linked ubiquitination of MKK6 at the same [[lysine]]. MKK6 could also stabilize TRIM9s by promoting the phosphorylation of TRIM9s at Ser76/80 via p38, thereby blocking the ubiquitin-proteasome pathway. Further functional analyses showed that p38 signaling plays a critical role in suppressing [[glioblastoma]] progression. Co-reduction of MKK6 and TRIM9s is significantly associated with overall poor survival of glioblastoma patients. 

Liu et al., identify a positive feedback loop in p38 signaling generated by MKK6-TRIM9s, which suppresses glioblastoma progression, and provide insights into the mechanisms by which TRIM9s and MKK6 potentiate p38 signaling through mutual stabilization
((Liu K, Zhang C, Li B, Xie W, Zhang J, Nie X, Tan P, Zheng L, Wu S, Qin Y, Cui 
J, Zhi F. Mutual Stabilization between TRIM9 Short Isoform and MKK6 Potentiates
p38 Signaling to Synergistically Suppress Glioblastoma Progression. Cell Rep.
2018 Apr 17;23(3):838-851. doi: 10.1016/j.celrep.2018.03.096. PubMed PMID:
29669288.
)).